Piper Jaffray analyst Joshua Schimmer was out pounding the table on Incyte Corporation (NASDAQ:INCY) Friday, reiterating an Overweight rating on the stock and raising the price target …
Cowen and Co.’s Eric Schmidt covers several companies in the biotechnology sector.
Incyte Corporation (NASDAQ:INCY) announced that it has entered into a multi-year research support and collaboration agreement with Vanderbilt-Ingram Cancer Center (VICC) at Vanderbilt University …
Incyte Corporation (NASDAQ:INCY) announced that it has created two new units to better position the organization for future growth in the U.S.
Oppenheimer analyst Christopher Marai came out with some insights on Incyte Corporation (NASDAQ:INCY) after detailed data from the baricitinib BUILD and BEACON P3 studies was …
In a research report issued today, Cowen & Co. analyst Eric Schmidt reiterated an Outperform rating on Incyte Corporation (NASDAQ:INCY), while no price target …
Eli Lilly and Company and Incyte Corporation (NASDAQ:INCY) announced that five abstracts featuring data from three clinical studies and separate pharmacology studies for …
Incyte Corporation (NASDAQ:INCY) announced that 23 abstracts detailing studies from its clinical development pipeline, including those conducted by Incyte, Novartis and independent investigators, …
J.P.
Recently, various executives have taken part in insider selling activity for the stocks of Skyworks Solutions Inc (NASDAQ:SWKS), Twitter Inc (NYSE:TWTR), salesforce.com, inc.
